Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1997-7-10
pubmed:abstractText
To define clinicopathologic features, response to treatment, and prognostic factors of primary mediastinal B-cell lymphoma (MBL), a CD20+ tumor recognized as a distinct entity among non-Hodgkin's lymphomas (NHL).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1646-53
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:9193365-Adolescent, pubmed-meshheading:9193365-Adult, pubmed-meshheading:9193365-Aged, pubmed-meshheading:9193365-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:9193365-Disease-Free Survival, pubmed-meshheading:9193365-Doxorubicin, pubmed-meshheading:9193365-Europe, pubmed-meshheading:9193365-Female, pubmed-meshheading:9193365-Humans, pubmed-meshheading:9193365-Lymphoma, B-Cell, pubmed-meshheading:9193365-Male, pubmed-meshheading:9193365-Middle Aged, pubmed-meshheading:9193365-Neoplasm Staging, pubmed-meshheading:9193365-Prognosis, pubmed-meshheading:9193365-Radiotherapy, Adjuvant, pubmed-meshheading:9193365-Retrospective Studies, pubmed-meshheading:9193365-Risk Factors, pubmed-meshheading:9193365-Survival Analysis, pubmed-meshheading:9193365-Thymus Neoplasms, pubmed-meshheading:9193365-Treatment Outcome
pubmed:year
1997
pubmed:articleTitle
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.
pubmed:affiliation
Department of Pathology, University of Pavia, Italy.
pubmed:publicationType
Journal Article, Multicenter Study